tiprankstipranks
Advertisement
Advertisement

HK:1276 Stock Latest News

Hengrui Pharma Wins NMPA Approval for First 0.1% Water-Free Cyclosporine Eye Drop in China
Company AnnouncementsHengrui Pharma Wins NMPA Approval for First 0.1% Water-Free Cyclosporine Eye Drop in China
23d ago
1276
Hengrui Wins Landmark NMPA Nod for New Lung Cancer Use of PD-L1 Drug
PremiumCompany Announcements
Hengrui Wins Landmark NMPA Nod for New Lung Cancer Use of PD-L1 Drug
23d ago
1276
Hengrui Pharma Wins NMPA Nod for New Dalpiciclib Breast Cancer Indication
PremiumCompany Announcements
Hengrui Pharma Wins NMPA Nod for New Dalpiciclib Breast Cancer Indication
1M ago
1276
Hengrui Pharma Wins NMPA Approval for First Domestic New-Generation URAT1 Inhibitor
PremiumCompany Announcements
Hengrui Pharma Wins NMPA Approval for First Domestic New-Generation URAT1 Inhibitor
2M ago
1276
Hengrui Pharma seals global collaboration and licensing deal with Bristol-Myers Squibb
PremiumCompany Announcements
Hengrui Pharma seals global collaboration and licensing deal with Bristol-Myers Squibb
2M ago
1276
Hengrui Pharma Sets Formal Remuneration and Evaluation Committee to Bolster Governance
PremiumCompany AnnouncementsHengrui Pharma Sets Formal Remuneration and Evaluation Committee to Bolster Governance
3M ago
1276
Hengrui Pharma Sets Nomination Committee to Tighten Board Governance
Premium
Company Announcements
Hengrui Pharma Sets Nomination Committee to Tighten Board Governance
3M ago
1276
Hengrui Pharma Assumes KiOmed License from Hansoh in Connected Deal
Premium
Company Announcements
Hengrui Pharma Assumes KiOmed License from Hansoh in Connected Deal
3M ago
1276
Jiangsu Hengrui Sets Detailed Mandate for Board Audit Committee
PremiumCompany Announcements
Jiangsu Hengrui Sets Detailed Mandate for Board Audit Committee
3M ago
1276
Hengrui Pharmaceuticals Posts Double-Digit Profit Growth in Strong Q1 2026
PremiumCompany Announcements
Hengrui Pharmaceuticals Posts Double-Digit Profit Growth in Strong Q1 2026
3M ago
1276
Jiangsu Hengrui Sets 2025 Final Dividend and Tax Terms for H Shares
PremiumCompany Announcements
Jiangsu Hengrui Sets 2025 Final Dividend and Tax Terms for H Shares
3M ago
1276
Jiangsu Hengrui Sets 2025 Final Dividend and Record Date for H Shareholders
PremiumCompany Announcements
Jiangsu Hengrui Sets 2025 Final Dividend and Record Date for H Shareholders
3M ago
1276
Hengrui Pharma Shareholders Approve Dividends, Board Changes at 2025 AGM
PremiumCompany AnnouncementsHengrui Pharma Shareholders Approve Dividends, Board Changes at 2025 AGM
3M ago
1276
Jiangsu Hengrui Outlines Board Composition and Key Governance Committees
Premium
Company Announcements
Jiangsu Hengrui Outlines Board Composition and Key Governance Committees
3M ago
1276
Jiangsu Hengrui Schedules Board Meeting to Approve First-Quarter 2026 Results
Premium
Company Announcements
Jiangsu Hengrui Schedules Board Meeting to Approve First-Quarter 2026 Results
3M ago
1276
Jiangsu Hengrui Pharmaceuticals Publishes 2025 Audited Annual Results
PremiumCompany Announcements
Jiangsu Hengrui Pharmaceuticals Publishes 2025 Audited Annual Results
4M ago
1276
Jiangsu Hengrui Pharmaceuticals Proposes Final 2025 Dividend
PremiumCompany Announcements
Jiangsu Hengrui Pharmaceuticals Proposes Final 2025 Dividend
4M ago
1276
Hengrui Pharma Sets 2025 AGM to Approve Dividends and 20% Share Issuance Mandate
PremiumCompany Announcements
Hengrui Pharma Sets 2025 AGM to Approve Dividends and 20% Share Issuance Mandate
4M ago
1276
Jiangsu Hengrui Boosts Investment in Shanghai Regenelead via RMB750 Million Capital Increase
PremiumCompany Announcements
Jiangsu Hengrui Boosts Investment in Shanghai Regenelead via RMB750 Million Capital Increase
4M ago
1276
Hengrui Subsidiary Wins NMPA Nod for New Indication of Innovative HER2 Breast Cancer Drug
PremiumCompany AnnouncementsHengrui Subsidiary Wins NMPA Nod for New Indication of Innovative HER2 Breast Cancer Drug
4M ago
1276
Hengrui Pharma Wins New China Approval for Hetrombopag Aplastic Anemia Use
Premium
Company Announcements
Hengrui Pharma Wins New China Approval for Hetrombopag Aplastic Anemia Use
4M ago
1276
Jiangsu Hengrui sets March 2026 board meeting to approve 2025 results
Premium
Company Announcements
Jiangsu Hengrui sets March 2026 board meeting to approve 2025 results
4M ago
1276

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >